{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T20:09:28Z","timestamp":1648843768424},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1157\/13071608","type":"journal-article","created":{"date-parts":[[2009,1,6]],"date-time":"2009-01-06T12:32:14Z","timestamp":1231245134000},"page":"67-70","source":"Crossref","is-referenced-by-count":3,"title":["Actividad de ertapenem y otros 19 antimicrobianos frente a Streptococcus pneumoniae y Haemophilus influenzae aislados del tracto respiratorio resistentes a betalact\u00e1micos"],"prefix":"10.1016","volume":"23","author":[{"given":"Jos\u00e9","family":"Luis G\u00f3mez-Garc\u00e9s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Ignacio Al\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Almudena","family":"Alhambra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Hern\u00e1iz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13071608_bib1","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1128\/AAC.45.6.1915-1918.2001","article-title":"In vitro activities of Ertapenem (MK-0826) against clinical bacterial isolates from 11 North American Medical Centers","volume":"45","author":"Fuchs","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13071608_bib2","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1128\/AAC.42.8.1996","article-title":"In vivo activity and pharmacoki-netic evaluation of a novel long-acting carbapenem antibiotic, MK-826 (L-749,345)","volume":"42","author":"Gill","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13071608_bib3","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1128\/AAC.41.8.1743","article-title":"Pharmacokinetics of L-749,345, a long-acting carbapenem antibiotic in primates","volume":"41","author":"Sundelof","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13071608_bib4","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1128\/AAC.45.6.1860-1867.2001","article-title":"In vitro activities of Ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia","volume":"45","author":"Livermore","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13071608_bib5","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1128\/AAC.43.8.1901","article-title":"Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. surveillance study","volume":"43","author":"Jacobs","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13071608_bib6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1157\/13050532","volume":"21","author":"Aracil","year":"2003","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1157\/13071608_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/jac\/47.2.215","article-title":"Antimicrobial resistance of Streptococcus pneumoniae isolates in 1999 and 2000 in Madrid, Spain: a multicenter surveillance study","volume":"47","author":"Oteo","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1157\/13071608_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/clinids\/15.1.77","article-title":"Antimicrobial resistance in Streptococcus pneumoniae - an overview","volume":"15","author":"Appelbaum","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13071608_bib9","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1128\/AAC.43.5.1310","article-title":"Emergence of fluoroquinolone resistance among multiply resistant strains of Streptococcus pneumoniae in Hong Kong","volume":"43","author":"Ho","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13071608_bib10","unstructured":"National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th ed. Approved standard. NCCLS publication M7\u2013A6. 2003. Wayne: National Committee for Clinical Laboratory Standards, 2003."}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X05749107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X05749107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T22:04:26Z","timestamp":1558044266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X05749107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0213005X05749107"],"URL":"https:\/\/doi.org\/10.1157\/13071608","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}